PHARMACEUTICAL EXECUTIVE NEWSLETTER

In this ISSUE

Country Report: Puerto Rico

Loss of Exclusivity: Strategies to Maximize Product Value

Pharm Exec’s 2017 Pipeline Report

Market Access

Strategies for Successful Market Access in the Untapped NASH Market

Jayachandra Reddy and Rishit Thakkar discuss the challenges facing early entrants in the Non-alcoholic Steatohepatitis market.
... /Read more/

RIM Best Practices: Unifying Data, Content & Regulatory Processes
On Demand

Learn more

Technology

How Data Science & Network Analytics Can Help Pharma Shift from Brand Centricity to Customer Centricity

Healthcare companies are overwhelming physicians and hospitals with brand messaging overlap. Let’s use data science to fix that, says Kevin Troyanos.
... /Read more/

Industry Trends

The Rising Tide of Next Generation Cancer Treatments

Jackie Ilacqua & Valerie Wriede trace the evolution of cancer treatment and drill down into the latest developments currently redefining the landscape, together with those on the horizon.
... /Read more/

Marketing

NASH: Pointers for Pharma from the Patient Perspective

With the NASH pipeline filling up fast, Mariel Metcalfe looks at what pharma companies need to do to ensure their products do not end up as also-rans in this dynamic new market segment.
... /Read more/

Reputation

Pharm Exec’s 16^th Annual Industry Audit

Our latest review reveals that those companies scoring well on profit management metrics are best positioned to maintain that crucial edge in performance execution.
... /Read more/

Launching into Value: Pharma's Quest to Align Drug Prices with Outcomes
Live Webcast: Wednesday, October 11 at 11:00am EDT

Calendar

/ Rare Diseases & Orphan Products Breakthrough Summit 10/16-10/17 /

/ Speed to IND for Biologics 10/19-10/20 /

update my profile / advertise with us / print & digital subscribe / visit pharmexec.com